0

small cell lung cancer spread to brain and liver

báo cáo hóa học:

báo cáo hóa học:" Randomized phase II study with two gemcitabine- and docetaxel-based combinations as first-line chemotherapy for metastatic non-small cell lung cancer" docx

Hóa học - Dầu khí

... G,Gozzelino F, Tonato M: Gemcitabine and cisplatin versus mito-mycin, ifosfamide, and cisplatin in advanced non -small- cell lung cancer: a randomized phase III study of the Italian Lung Cancer Project. ... J Cancer 2001, 94:153-156.2. Non -small Cell Lung Cancer Collaborative Group: Chemotherapyin non small cell lung cancer: a meta-analysis using updateddata on individual patients from 52 randomized ... Di Costanzo F, Frontini L, Tonato M: Italian Lung Cancer Project. Phase III randomized trial comparingthree platinum-based doublets in advanced non small- cell lung cancer. J Clin Oncol 2002,...
  • 8
  • 538
  • 0
Báo cáo khoa học:

Báo cáo khoa học: "Analysis of clinical and dosimetric factors associated with severe acute radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with concurrent chemotherapy and intensity-modulated radiotherapy" pot

Báo cáo khoa học

... non -small cell lung cancer treated with concurrent chemotherapy and intensity-modulated radiotherapyAnhui Shi, Guangying Zhu*, Hao Wu, Rong Yu, Fuhai Li and Bo XuAbstractBackground: To evaluate ... clinical, dosimetric factors and severe acute radiation pneumonitis (SARP) in patients with locally advanced non -small cell lung cancer (LANSCLC) treated with concurrent chemotherapy and intensity-modulated ... standard method forthe management of unresectable locally advanced non- small cell lung cancer (NSCLC). Unfortunately, the longersurvival is achieved at the price of greater toxicity of thelung...
  • 8
  • 371
  • 0
Báo cáo hóa học:

Báo cáo hóa học: " Detection of EGFR mutations with mutation-specific antibodies in stage IV non-small-cell lung cancer" pdf

Hóa học - Dầu khí

... mutations in lung cancer patients.Methods: EGFR mutation status was analyzed by DNA assays, and compared with IHC results in five non -small- cell lung cancer (NSCLC) cell lines and tumor samples ... Non -small- cell lung cancer harbouring mutations in the EGFRkinase domain. Clin Transl Oncol 2010, 12:75-80.9. Gazdar AF: Activating and resistance mutations of EGFR in non -small- cell lung cancer: ... epidermal growth factorreceptor mutation-specific antibodies for non -small cell lung cancer: immunohistochemistry as a possible screening method for epidermalgrowth factor receptor mutations. J...
  • 8
  • 798
  • 0
Báo cáo hóa học:

Báo cáo hóa học: "Involvement of aryl hydrocarbon receptor signaling in the development of small cell lung cancer induced by HPV E6/E7 oncoproteins" ppt

Hóa học - Dầu khí

... Martinelli1,4*AbstractBackground: Lung cancers consist of four major types that and for clinical-pathological reasons are often dividedinto two broad categories: small cell lung cancer (SCLC) and non -small cell lung cancer ... Schwemberger S, Tomlinson CR, Sartor MA, et al:Ligand-independent regulation of transforming growth factor β1expression and cell cycle progression by the aryl hydrocarbon receptor.Mol Cell Biol ... cancers, and might have a role in other malignancies including vulva, skin, oesophagus, head and neck cancer. HPV has also been speculated to have a role in the pathogenesis of lung cancer. To...
  • 11
  • 471
  • 0
Báo cáo hóa học:

Báo cáo hóa học: "Prognostic Impact of MiR-155 in Non-Small Cell Lung Cancer Evaluated by in Situ Hybridization" pot

Hóa học - Dầu khí

... tumor cells versus stromal cells in non small cell lung cancer. Clin Cancer Res 2007, 13:6649-57.24. World Health Organization: Histological Typing of Lung and PleuralTumours. Geneva, Switzerland: ... according to NSCLC histology. Lung Cancer 2010.31. Donnem T, Al-Saad S, Al-Shibli K, Andersen S, Busund LT, Bremnes RM:Prognostic impact of platelet-derived growth factors in non -small cell lung cancer ... various histologicalsubtypes and stages of lung cancer may help to predictthetoxicityandsusceptibility to future RNA targetedtherapies.Figure 2 Disease-specific survival curves according to miR-155expression...
  • 9
  • 662
  • 0
báo cáo hóa học:

báo cáo hóa học: " Health state utilities for non small cell lung cancer" pot

Hóa học - Dầu khí

... approximately 29,000 people died from lung cancer in England and Wales[1] and it is the most com-mon and the most life-threatening form of cancer in Scot-land [2]. Lung cancer is also a major cause ... Staging of small cell and non -small cell lung cancer. University of Iowa Virtual Hos-pital; 1999. 6. Hopwood P, Stephens RJ: Symptoms at presentation for treat-ment in patients with lung cancer: ... were randomized into two selections (A and B) ofprogressive, stable and responding health states and toxic-ities. All participants were randomly assigned to rate thefollowing: stable and responding...
  • 15
  • 397
  • 0
Báo cáo toán học:

Báo cáo toán học: "Molecular Predictors of EGFR-TKI Sensitivity in Advanced Non–small Cell Lung Cancer" ppsx

Báo cáo khoa học

... Lung cancer is one of the most common human cancers and the leading cause of cancer death world-wide (1). Lung cancer is generally classified into two histological types, small cell lung cancer ... sensitivity to gefitinib in non -small cell lung cancer cell lines. Mol Cancer Res. 2006; 4(8): 521-8. 102. Taguchi F, Solomon B, Gregorc V, et al. Mass spectrometry to classify non -small- cell lung cancer ... growth factor receptor and non -small- cell lung cancer. J Med Genet. 2007; 44(3): 166-72. 41. Riely GJ, Pao W, Pham D, et al. Clinical course of patients with non -small cell lung cancer and epidermal...
  • 9
  • 203
  • 0
Báo cáo khoa học:

Báo cáo khoa học: "Pathological complete response induced by first-line chemotherapy with single agent docetaxel in a patient with advanced non small cell lung cancer" pptx

Báo cáo khoa học

... tumorshrinkage, with no additional toxicity, and gave thepatient the possibility to undergo a lobectomy ratherthan a pneumectomy, with the obvious advantages of aless invasive and more limited surgical ... agentdocetaxel in a patient with advanced non small cell lung cancer Ferdinando Riccardi1*, Giuseppe Di Lorenzo1, Carlo Buonerba1, Guglielmo Monaco2, Roberto Monaco3,Mimma Rizzo1, Sarah Scagliarini1, ... obtain a response after the first few cycles should notautomatically discourage to continue treatment.IntroductionIn non -small cell lung cancer (NSCLC), mediastinallymphnode involvement comprises...
  • 4
  • 303
  • 0
Báo cáo khoa học:

Báo cáo khoa học: "Clinical outcomes of stereotactic body radiotherapy for stage I non-small cell lung cancer using different doses depending on tumor size" ppsx

Báo cáo khoa học

... non -small cell lung cancer. Lung Cancer 2003,41:1-11.17. Shibamoto Y, Yukawa Y, Tsutsui K, Takahashi M, Abe M: Variation in thehypoxic fraction among mouse tumors of different types, sizes, and sites. ... 75:343-347.11. Baba F, Shibamoto Y, Tomita N, Ikeya-Hashizume C, Oda K, Ayakawa S,Ogino H, Sugie C: Stereotactic body radiotherapy for stage I lung cancer and small lung metastasis: evaluation ... non -small- cell lung cancer: clinical implications. Radiother Oncol2010, 94:1-11.27. Chen Y, Guo W, Lu Y, Zou B: Dose-individualized stereotactic bodyradiotherapy for T1-3N0 non -small cell lung...
  • 7
  • 297
  • 0
Báo cáo khoa học:

Báo cáo khoa học: "The effect of bioequivalent radiation dose on survival of patients with limited-stage small-cell lung cancer" pdf

Báo cáo khoa học

... interruptions to palliate thetoxicity from concurrent chemoradiation for limited small cell lung cancer decreases survival and disease control. Lung Cancer 2001,33:249-258.26. Cisplatin, etoposide, and ... morphological characteristics ofpermanent human small cell lung cancer cell lines. J Cancer Res ClinOncol 1987, 113:31-40.16. NCCN guidelines for small- cell lung cancer. [http://www.nccn.org/professionals/physician_gls/f_guidelines.asp].17. ... in limited-stage small cell lung cancer: facts, questions, prospects. Radiother Oncol 2000, 55:1-9.2. Murray N, Turrisi AT: A review of first-line treatment for small- cell lung cancer. J Thorac...
  • 9
  • 465
  • 0
Báo cáo khoa học:

Báo cáo khoa học: " Comparison of outcomes in patients with stage III versus limited stage IV non-small cell lung cancer" docx

Báo cáo khoa học

... Stereotactic Body Rad iotherapy, Oligometastases, Non -Small Cell Lung Cancer BackgroundNon -small cell lung cancer (NSCLC) is the leadingcause of cancer mortality in the United States [1].Patients ... and was postulated to be a poor prognostic factor in lung cancer. Similarly,Bradley et al. demonstrated the prognostic value ofGTV determined on planning CT scans to be associatedwith OS and ... limited stage IV non -small cell lung cancer Praveena Cheruvu1, Su K Metcalfe1, Justin Metcalfe1, Yuhchyau Chen1, Paul Okunieff2 and Michael T Milano1*AbstractBackground: Standard therapy...
  • 7
  • 368
  • 0

Xem thêm